What is the Safe Observation Period for Image-Guided Percutaneous Liver Biopsies?
Purpose Current observation period post-liver biopsy is typically 4 h. This study investigates the safety of reducing the observation period after percutaneous liver biopsy. Methods Patients who underwent percutaneous liver biopsy between 2017 and 2022 in the Radiology Department of a tertiary centr...
Gespeichert in:
Veröffentlicht in: | Cardiovascular and interventional radiology 2024-10, Vol.47 (10), p.1327-1334 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1334 |
---|---|
container_issue | 10 |
container_start_page | 1327 |
container_title | Cardiovascular and interventional radiology |
container_volume | 47 |
creator | Sehgal, Kunal Taylor, Fergus Van Wees, Matthew Li, Kenny De Boo, Diederick Willem Slater, Lee Anne |
description | Purpose
Current observation period post-liver biopsy is typically 4 h. This study investigates the safety of reducing the observation period after percutaneous liver biopsy.
Methods
Patients who underwent percutaneous liver biopsy between 2017 and 2022 in the Radiology Department of a tertiary centre were included in this retrospective, institutional review board-approved study. Patient demographics, procedure details and complication data were collected from the electronic medical records. Complications were graded according to the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) classification. Conditional survival probabilities were calculated for the 4-h observation period.
Results
Among 1125 patients, 275 complications were seen; 255 grade 1, 15 grade 2 and five grade 3. Post-procedural pain represented 93% (256) of complications, whereas post-procedural haemorrhage occurred in 17 (6%) patients: 13 were of grade 2 severity requiring prolonged observation, and 4 were of grade 3 severity. Of these grade 3 complications, two required blood transfusion whereas two required embolization. A total of 215 (78%) complications occurred within 1 h, 244 (89%) within 2 h of observation. 16 (94%) of 17 post-procedural haemorrhages occurred within 2 h post-biopsy. If complication-free after 2 h, the probability of experiencing a complication within the next 2 h was 4%.
Conclusion
The majority of complications were identified within 2 h of observation. Complications recognised after this period were largely pain-related, with only one grade 3 complication seen (post-procedural haemorrhage).Our findings suggest 2 h of post-procedural observation may be safe.
Level of Evidence
: Level 2B, Retrospective Cohort Study.
Graphical Abstract |
doi_str_mv | 10.1007/s00270-024-03800-2 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3086066531</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3086066531</sourcerecordid><originalsourceid>FETCH-LOGICAL-c256t-5f34aece1809fc91e4cba17324d3487d9faf7fc2ba72bb69f6386ab08bbec95c3</originalsourceid><addsrcrecordid>eNp9kE1P3DAQhq0KVBbaP9ADssSlF8PYjuP4hFrEl7QSVG3V3izbGYPR7maxEyT-PdmGD6kHTiPNPPPO6CHkC4dDDqCPCoDQwEBUDGQDwMQHMuOVFAya-u8WmQHXFeNK8R2yW8odAFeNUB_JjjSgm8qoGfnx59b1NBXa3yL96SLSK18wP7g-dSt6jTl1LY1dppdLd4PsfEgttpt-GHq3wm4odJ4eMNPvqVuXhOX4E9mOblHw83PdI7_PTn-dXLD51fnlybc5C0LVPVNRVg4D8gZMDIZjFbzjWoqqlVWjWxNd1DEI77Twvjaxlk3tPDTeYzAqyD3ydcpd5-5-wNLbZSoBF4vpLStHCVDXSvIRPfgPveuGvBq_s5JzrY0QZkOJiQq5KyVjtOucli4_Wg52I9xOwu0o3P4TbsW4tP8cPfgltq8rL4ZHQE5AGUerG8xvt9-JfQKkSora</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3117792291</pqid></control><display><type>article</type><title>What is the Safe Observation Period for Image-Guided Percutaneous Liver Biopsies?</title><source>SpringerNature Journals</source><creator>Sehgal, Kunal ; Taylor, Fergus ; Van Wees, Matthew ; Li, Kenny ; De Boo, Diederick Willem ; Slater, Lee Anne</creator><creatorcontrib>Sehgal, Kunal ; Taylor, Fergus ; Van Wees, Matthew ; Li, Kenny ; De Boo, Diederick Willem ; Slater, Lee Anne</creatorcontrib><description>Purpose
Current observation period post-liver biopsy is typically 4 h. This study investigates the safety of reducing the observation period after percutaneous liver biopsy.
Methods
Patients who underwent percutaneous liver biopsy between 2017 and 2022 in the Radiology Department of a tertiary centre were included in this retrospective, institutional review board-approved study. Patient demographics, procedure details and complication data were collected from the electronic medical records. Complications were graded according to the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) classification. Conditional survival probabilities were calculated for the 4-h observation period.
Results
Among 1125 patients, 275 complications were seen; 255 grade 1, 15 grade 2 and five grade 3. Post-procedural pain represented 93% (256) of complications, whereas post-procedural haemorrhage occurred in 17 (6%) patients: 13 were of grade 2 severity requiring prolonged observation, and 4 were of grade 3 severity. Of these grade 3 complications, two required blood transfusion whereas two required embolization. A total of 215 (78%) complications occurred within 1 h, 244 (89%) within 2 h of observation. 16 (94%) of 17 post-procedural haemorrhages occurred within 2 h post-biopsy. If complication-free after 2 h, the probability of experiencing a complication within the next 2 h was 4%.
Conclusion
The majority of complications were identified within 2 h of observation. Complications recognised after this period were largely pain-related, with only one grade 3 complication seen (post-procedural haemorrhage).Our findings suggest 2 h of post-procedural observation may be safe.
Level of Evidence
: Level 2B, Retrospective Cohort Study.
Graphical Abstract</description><identifier>ISSN: 0174-1551</identifier><identifier>ISSN: 1432-086X</identifier><identifier>EISSN: 1432-086X</identifier><identifier>DOI: 10.1007/s00270-024-03800-2</identifier><identifier>PMID: 39078495</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Biopsy ; Blood transfusion ; Cardiology ; Clinical Investigation ; Electronic medical records ; Embolization ; Hemorrhage ; Imaging ; Liver ; Medicine ; Medicine & Public Health ; Non-Vascular Interventions ; Nuclear Medicine ; Pain ; Radiology ; Ultrasound</subject><ispartof>Cardiovascular and interventional radiology, 2024-10, Vol.47 (10), p.1327-1334</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2024. Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c256t-5f34aece1809fc91e4cba17324d3487d9faf7fc2ba72bb69f6386ab08bbec95c3</cites><orcidid>0009-0001-6275-9878</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00270-024-03800-2$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00270-024-03800-2$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39078495$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sehgal, Kunal</creatorcontrib><creatorcontrib>Taylor, Fergus</creatorcontrib><creatorcontrib>Van Wees, Matthew</creatorcontrib><creatorcontrib>Li, Kenny</creatorcontrib><creatorcontrib>De Boo, Diederick Willem</creatorcontrib><creatorcontrib>Slater, Lee Anne</creatorcontrib><title>What is the Safe Observation Period for Image-Guided Percutaneous Liver Biopsies?</title><title>Cardiovascular and interventional radiology</title><addtitle>Cardiovasc Intervent Radiol</addtitle><addtitle>Cardiovasc Intervent Radiol</addtitle><description>Purpose
Current observation period post-liver biopsy is typically 4 h. This study investigates the safety of reducing the observation period after percutaneous liver biopsy.
Methods
Patients who underwent percutaneous liver biopsy between 2017 and 2022 in the Radiology Department of a tertiary centre were included in this retrospective, institutional review board-approved study. Patient demographics, procedure details and complication data were collected from the electronic medical records. Complications were graded according to the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) classification. Conditional survival probabilities were calculated for the 4-h observation period.
Results
Among 1125 patients, 275 complications were seen; 255 grade 1, 15 grade 2 and five grade 3. Post-procedural pain represented 93% (256) of complications, whereas post-procedural haemorrhage occurred in 17 (6%) patients: 13 were of grade 2 severity requiring prolonged observation, and 4 were of grade 3 severity. Of these grade 3 complications, two required blood transfusion whereas two required embolization. A total of 215 (78%) complications occurred within 1 h, 244 (89%) within 2 h of observation. 16 (94%) of 17 post-procedural haemorrhages occurred within 2 h post-biopsy. If complication-free after 2 h, the probability of experiencing a complication within the next 2 h was 4%.
Conclusion
The majority of complications were identified within 2 h of observation. Complications recognised after this period were largely pain-related, with only one grade 3 complication seen (post-procedural haemorrhage).Our findings suggest 2 h of post-procedural observation may be safe.
Level of Evidence
: Level 2B, Retrospective Cohort Study.
Graphical Abstract</description><subject>Biopsy</subject><subject>Blood transfusion</subject><subject>Cardiology</subject><subject>Clinical Investigation</subject><subject>Electronic medical records</subject><subject>Embolization</subject><subject>Hemorrhage</subject><subject>Imaging</subject><subject>Liver</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Non-Vascular Interventions</subject><subject>Nuclear Medicine</subject><subject>Pain</subject><subject>Radiology</subject><subject>Ultrasound</subject><issn>0174-1551</issn><issn>1432-086X</issn><issn>1432-086X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kE1P3DAQhq0KVBbaP9ADssSlF8PYjuP4hFrEl7QSVG3V3izbGYPR7maxEyT-PdmGD6kHTiPNPPPO6CHkC4dDDqCPCoDQwEBUDGQDwMQHMuOVFAya-u8WmQHXFeNK8R2yW8odAFeNUB_JjjSgm8qoGfnx59b1NBXa3yL96SLSK18wP7g-dSt6jTl1LY1dppdLd4PsfEgttpt-GHq3wm4odJ4eMNPvqVuXhOX4E9mOblHw83PdI7_PTn-dXLD51fnlybc5C0LVPVNRVg4D8gZMDIZjFbzjWoqqlVWjWxNd1DEI77Twvjaxlk3tPDTeYzAqyD3ydcpd5-5-wNLbZSoBF4vpLStHCVDXSvIRPfgPveuGvBq_s5JzrY0QZkOJiQq5KyVjtOucli4_Wg52I9xOwu0o3P4TbsW4tP8cPfgltq8rL4ZHQE5AGUerG8xvt9-JfQKkSora</recordid><startdate>20241001</startdate><enddate>20241001</enddate><creator>Sehgal, Kunal</creator><creator>Taylor, Fergus</creator><creator>Van Wees, Matthew</creator><creator>Li, Kenny</creator><creator>De Boo, Diederick Willem</creator><creator>Slater, Lee Anne</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0009-0001-6275-9878</orcidid></search><sort><creationdate>20241001</creationdate><title>What is the Safe Observation Period for Image-Guided Percutaneous Liver Biopsies?</title><author>Sehgal, Kunal ; Taylor, Fergus ; Van Wees, Matthew ; Li, Kenny ; De Boo, Diederick Willem ; Slater, Lee Anne</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c256t-5f34aece1809fc91e4cba17324d3487d9faf7fc2ba72bb69f6386ab08bbec95c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Biopsy</topic><topic>Blood transfusion</topic><topic>Cardiology</topic><topic>Clinical Investigation</topic><topic>Electronic medical records</topic><topic>Embolization</topic><topic>Hemorrhage</topic><topic>Imaging</topic><topic>Liver</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Non-Vascular Interventions</topic><topic>Nuclear Medicine</topic><topic>Pain</topic><topic>Radiology</topic><topic>Ultrasound</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sehgal, Kunal</creatorcontrib><creatorcontrib>Taylor, Fergus</creatorcontrib><creatorcontrib>Van Wees, Matthew</creatorcontrib><creatorcontrib>Li, Kenny</creatorcontrib><creatorcontrib>De Boo, Diederick Willem</creatorcontrib><creatorcontrib>Slater, Lee Anne</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Cardiovascular and interventional radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sehgal, Kunal</au><au>Taylor, Fergus</au><au>Van Wees, Matthew</au><au>Li, Kenny</au><au>De Boo, Diederick Willem</au><au>Slater, Lee Anne</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>What is the Safe Observation Period for Image-Guided Percutaneous Liver Biopsies?</atitle><jtitle>Cardiovascular and interventional radiology</jtitle><stitle>Cardiovasc Intervent Radiol</stitle><addtitle>Cardiovasc Intervent Radiol</addtitle><date>2024-10-01</date><risdate>2024</risdate><volume>47</volume><issue>10</issue><spage>1327</spage><epage>1334</epage><pages>1327-1334</pages><issn>0174-1551</issn><issn>1432-086X</issn><eissn>1432-086X</eissn><abstract>Purpose
Current observation period post-liver biopsy is typically 4 h. This study investigates the safety of reducing the observation period after percutaneous liver biopsy.
Methods
Patients who underwent percutaneous liver biopsy between 2017 and 2022 in the Radiology Department of a tertiary centre were included in this retrospective, institutional review board-approved study. Patient demographics, procedure details and complication data were collected from the electronic medical records. Complications were graded according to the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) classification. Conditional survival probabilities were calculated for the 4-h observation period.
Results
Among 1125 patients, 275 complications were seen; 255 grade 1, 15 grade 2 and five grade 3. Post-procedural pain represented 93% (256) of complications, whereas post-procedural haemorrhage occurred in 17 (6%) patients: 13 were of grade 2 severity requiring prolonged observation, and 4 were of grade 3 severity. Of these grade 3 complications, two required blood transfusion whereas two required embolization. A total of 215 (78%) complications occurred within 1 h, 244 (89%) within 2 h of observation. 16 (94%) of 17 post-procedural haemorrhages occurred within 2 h post-biopsy. If complication-free after 2 h, the probability of experiencing a complication within the next 2 h was 4%.
Conclusion
The majority of complications were identified within 2 h of observation. Complications recognised after this period were largely pain-related, with only one grade 3 complication seen (post-procedural haemorrhage).Our findings suggest 2 h of post-procedural observation may be safe.
Level of Evidence
: Level 2B, Retrospective Cohort Study.
Graphical Abstract</abstract><cop>New York</cop><pub>Springer US</pub><pmid>39078495</pmid><doi>10.1007/s00270-024-03800-2</doi><tpages>8</tpages><orcidid>https://orcid.org/0009-0001-6275-9878</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0174-1551 |
ispartof | Cardiovascular and interventional radiology, 2024-10, Vol.47 (10), p.1327-1334 |
issn | 0174-1551 1432-086X 1432-086X |
language | eng |
recordid | cdi_proquest_miscellaneous_3086066531 |
source | SpringerNature Journals |
subjects | Biopsy Blood transfusion Cardiology Clinical Investigation Electronic medical records Embolization Hemorrhage Imaging Liver Medicine Medicine & Public Health Non-Vascular Interventions Nuclear Medicine Pain Radiology Ultrasound |
title | What is the Safe Observation Period for Image-Guided Percutaneous Liver Biopsies? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T23%3A35%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=What%20is%20the%20Safe%20Observation%20Period%20for%20Image-Guided%20Percutaneous%20Liver%20Biopsies?&rft.jtitle=Cardiovascular%20and%20interventional%20radiology&rft.au=Sehgal,%20Kunal&rft.date=2024-10-01&rft.volume=47&rft.issue=10&rft.spage=1327&rft.epage=1334&rft.pages=1327-1334&rft.issn=0174-1551&rft.eissn=1432-086X&rft_id=info:doi/10.1007/s00270-024-03800-2&rft_dat=%3Cproquest_cross%3E3086066531%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3117792291&rft_id=info:pmid/39078495&rfr_iscdi=true |